Jury Hits Takeda Over Amitiza Deal, Opening Door to Multi-Billion Dollar Antitrust Blow
A federal jury in Boston has delivered a costly verdict against Japanese drugmaker Takeda Pharmaceutical Company, concluding that the company used an unlawful strategy to keep cheaper versions of its constipation medicine Amitiza off the U.S. market for years. The panel found Takeda responsible for roughly $885 million in damages after siding with wholesalers, insurers, …
Jury Hits Takeda Over Amitiza Deal, Opening Door to Multi-Billion Dollar Antitrust Blow Read More »











